Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03837119
NCT03837119
Completed
Not Applicable

Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies

University Hospital, Basel, Switzerland2 sites in 1 country540 target enrollmentApril 4, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHeterozygous Haemoglobinopathy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heterozygous Haemoglobinopathy
Sponsor
University Hospital, Basel, Switzerland
Enrollment
540
Locations
2
Primary Endpoint
cholestasis in pregnancy
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This retrospective study aims to investigate pregnancy outcome in women with heterozygous hemoglobinopathies (regarding gestational diabetes, cholestasis and urinary tract infections) and to analyze if there are aggravated maternal and/or perinatal risks.

Registry
clinicaltrials.gov
Start Date
April 4, 2018
End Date
April 11, 2021
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •pregnant women with or without heterozygous hemoglobinopathy

Exclusion Criteria

  • •refusal of study participation

Outcomes

Primary Outcomes

cholestasis in pregnancy

Time Frame: in the course of pregnancy until delivery

number of women developing cholestasis in pregnancy

urinary tract infection

Time Frame: in the course of pregnancy until delivery

number of women developing urinary tract infection

gestational diabetes

Time Frame: in the course of pregnancy until delivery

number of women developing gestational diabetes in pregnancy

Study Sites (2)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Effect of Different Maternal Hemoglobin and Hematocrit Values on Perinatal OutcomeHemoglobin and Hematocrit Values on Perinatal Outcome
NCT06726915Ali Mohamed Mohamed Ammar403
Not yet recruiting
Phase 4
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency AnemiaAnemia, Iron DeficiencyPregnancy Anemia
NCT06061393Western Galilee Hospital-Nahariya200
Active, not recruiting
Not Applicable
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During PregnancyMigraine
NCT05198245Pfizer1
Completed
Not Applicable
Pregnancy and Fibrinogen DisordersHypofibrinogenemia, CongenitalAfibrinogenemia, CongenitalDysfibrinogenemia, Congenital
NCT03920332University Hospital, Geneva149
Completed
Not Applicable
Screening for Hemoglobinopathies in Pregnant WomenHemoglobinopathies
NCT04029142University Hospital, Basel, Switzerland1,785